Changing epidemiology and natural history of valvular heart disease

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 10, Issue 2, 2010, Pages 168-171

  Ray, Simon ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA VALVE REGURGITATION; DISEASE COURSE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HEART HEMODYNAMICS; HEART INFARCTION; HUMAN; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; UNITED STATES; VALVULAR HEART DISEASE;

EID: 77950561212     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.10-2-168     Document Type: Review

References (22)

1. Nkomo VT, Gardin JM, Skelton TN et al. Burden of valvular heart disease: a population-based study. Lancet 2006;368:1005-1011 (Pubitemid 44353666)
2. Nkomo VT. Epidemiology and prevention of valvular heart disease and infective endocarditis in Africa. Heart 2007;93:1510-1519
3. Marijon E, Ou P, Celermajer DS et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007;357:470-476 (Pubitemid 47204876)
4. www.statistics.gov.uk
5. The Society for Cardiothoracic Surgery in GB and Ireland (SCTS). The sixth national cardiac surgical database report. Henleyon-Thames: Dendrite Clinical Systems, 2009.
6. Bonow RO, Carabello BA, Chatterjee K et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease); Society of Cardiovascular Anesthesiologists. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. A report of the ACC/AHA Task Force on Practice Guidelines (Writing Committee), developed in collaboration with the Society of Cardiovascular Anesthesiologists, endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006;48:e1-148.
7. Stewart BF, Siscovick D, Lind BK et al. Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study. J Am Coll Cardiol 1997;29:630-634
8. Novaro GM, Katz R, Aviles RJ et al. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study. J Am Coll Cardiol 2007;50:1992-1998 (Pubitemid 350046337)
9. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005;111:920-925
10. Rosseb A, Pedersen T, Boman K et al. Intensive lipid lowering with simvastatin and eztimibe in aortic stenosis. N Engl J Med 2008;359:1343-1356
11. Roberts WC, Ko JM, Moore TR, Jones WH 3rd. Causes of pure aortic regurgitation in patients having isolated aortic valve replacement at a single US tertiary hospital (1993 to 2005). Circulation 2006;114:422-429
12. Van Camp G, Flamez A, Cosyns B et al. Treatment of Parkinson's disease with pergolide and relation to restrictive valvular disease. Lancet 2004;363:1179-1183 (Pubitemid 38481842)
13. Freed LA, Levy D, Levine RA et al. Prevalence and clinical outcome of mitralvalve prolapse. N Engl J Med 1999;341:1-7. (Pubitemid 29293713)
14. Avierinos JF, Gersh BJ, Melton J 3rd et al. Natural history of asymptomatic mitral valve prolapse in the community. Circulation 2002;106:1355-1361
15. Ling LH, Enriquez-Sarano M, Seward JB et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 1996;335;1417-1423 (Pubitemid 26382502)
16. Avierinos JF, Inamo J, Grigioni F et al. Sex differences in morphology and outcomes of mitral valve prolapse. Ann Intern Med 2008;149:787-795
17. Enriquez-Sarano M, Avierinos JF,Messika-Zeitoun D et al. Quantitative determinants of asymptomatic mitral regurgitation. N Engl J Med 2005;352:875-883 (Pubitemid 40300296)
18. Bursi F, Enriquez-Sarano M, Nkomo VT et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation 2005;111:295-301. (Pubitemid 40165335)
19. Pellizon GG, Grines CL, Cox DA et al. Importance of mitral regurgitation in patients underlying percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complication (CADILLAC) trial. J Am Coll Cardiol 2004;43:1368-1374 (Pubitemid 38496340)
20. Perez de Isla L, Zamorano J, Quezada M et al. Prognostic significance of functional mitral regurgitation after a first non-ST-segment elevation acute coronary syndrome. Eur Heart J 2006;27:2655-2660 (Pubitemid 44729864)
21. Mihaljevic T, Lam BK, Rajeswaran J et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol 2007;49:2191-2201 (Pubitemid 46817809)
22. Sagie A, Freitas N, Padial LR et al. Doppler echocardiographic assessment of long-term prognosis of mitral stenosis in 103 patients: valve area and right heart disease. J Am Coll Cardiol 1996;28:472-479 (Pubitemid 26274346)